Pharmaceutico Analytical Study of Mukta Shukti Bhasma

  • Dr. Biradar M. H. Associate Professor & HOD, Department of Agada Tantra & Vyavahara Ayurveda, BLDEA’S AVS Ayurveda Mahavidyalaya, Vijayapur, Karnataka, India.
  • Shankar Gowda Professor, Department of Rasashastra & Bhaishajya Kalpana, Taranath Govt. Ayurvedic Medical College, Ballary, Karnataka, India.
  • Madhav Diggavi Professor, Department of Kayachikitsa, Taranath Govt. Ayurvedic Medical College, Ballary, Karnataka, India.
Keywords: Pearl oyster, Mukta Shukti Bhasma, Kumari Swarasa, Kanji, Gajaputa, XRD

Abstract

Background: Mukta Shukti is an aquamarine calcium carbonate compound. Mukta Shukti Bhasma is a classical ethical economical medicament, effective in general practice, pharmaceutical processing as per texts with systematic observation and technological updating is carried out in the present work. Objectives: To prepare Mukta Shukti Bhasma by different Pharmaceutical processes and carry out the analytical study. Materials and Methods: Grahya Ashodhita Mukta Shukti was subjected to Shodhana by Kanji Swedana for 3 hours and then divided into two parts. The first part of Shodhita Mukata Shukti was incinerated totally and after 1st Puta it was divided into two portions, first portion was subjected to Jala Bhavana and incinerated. The second portion was subjected to Kumari Swarasa Bhavana and incinerated. The second part of Shodhita Mukata Shukti was incinerated in Kumari Samputa and subjected to Kumari Swarasa Bhavana and incinerated until they attain Bhasma Siddhi Lakshanas and later all the three samples were subjected to analytical studies. Results: Mukta Shukti Bhasma by Jala Bhavana method, Kumari Bhavana method, and Kumari Samputa method requires 7, 6 and 3 Gajaputas respectively with an average of 324 cow dungs in each and at 793°C temperature. Conclusion: Kumari Bhavita Marana to Mukta Shukti leads to calcite form and Jala Bhavita Marana leads to calcium oxide hydrate form. Chemically Mukta Shukti Bhasma may be in both calcite and calcium oxide hydrate form, and XRD is a method in Standardization of Mukta Shukti Bhasma.

Downloads

Download data is not yet available.

References

Pal D, Sahu CK, Haldar A. Bhasma : The ancient Indian nanomedicine. Journal of Advanced Pharmaceutical Technology & Research. 2014;5(1):4-12. doi:10.4103/2231-4040.126980.

Mishra LC, Adra T, Batchu SV, Bhatt HA. LLC Boca Raton, Florida: CRC Press; 2004. Scientific basis for ayurvedic therapies; pp. 84–99.

N. V. Vardhini, T. N. Sathya, P. Balakrishna Murthy, Assessment of genotoxic potential of herbomineral preparations - bhasmas, Current Science, Vol. 99, No. 8, 25 October 2010.

Ramachandra Reddy K. Bhaishajya Kalpana Vijnana. 3rd ed. Varanasi: Chawkhamba Sanskrit Bhavan; 2004;p.418.

Sadananda Sharma, Rasa Tarangini, Kashinath Shastry ed, New Delhi, Motilal Banarasidas publication, 12th chapter, 2000;p.296.

Shyamasundar Acharya, Rasayana Sara part 1, Varanasi, Krishnadas Academy, 5th edition, 2002;p.327

Indian Herbal pharmacopoeia, Volume I, Mumbai, A Joint Publication of Regional Research Laboratory Jammu and Indian Drug manufactur’s Association, 180 - 181 pp.

C.V.S. Subramanyam, Text Book of Physical Pharmaceuties, 2nd edn, Vallabha Prakashan, 2000, P. 195-200.

Biotechnology - 3including molecular biology, bio physics, by S. Mahesh, new age international publishers, Delhi, part B, 9th chapter 282-284pp.

Turner RA, Analgesic in screening method cited in pharmacology edition turner or a academic press London, New York, 1952,110-117pp

Namburi Hanumanth Rao, Manual of Namburi phased Spot test, Vijayawada, Namburi Inventions and Publication, 1997;p.2.
CITATION
DOI: 10.21760/jaims.v2i04.245
Published: 2017-08-31
How to Cite
Dr. Biradar M. H., Shankar Gowda, & Madhav Diggavi. (2017). Pharmaceutico Analytical Study of Mukta Shukti Bhasma. Journal of Ayurveda and Integrated Medical Sciences, 2(04), 89-99. https://doi.org/10.21760/jaims.v2i04.245
Section
Original Article